124 related articles for article (PubMed ID: 7655826)
21. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells.
Jilek S; Merkle HP; Walter E
Adv Drug Deliv Rev; 2005 Jan; 57(3):377-90. PubMed ID: 15560947
[TBL] [Abstract][Full Text] [Related]
22. PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines.
Waeckerle-Men Y; Groettrup M
Adv Drug Deliv Rev; 2005 Jan; 57(3):475-82. PubMed ID: 15560953
[TBL] [Abstract][Full Text] [Related]
23. Microparticles for the delivery of DNA vaccines.
O'Hagan DT; Singh M; Ulmer JB
Immunol Rev; 2004 Jun; 199():191-200. PubMed ID: 15233735
[TBL] [Abstract][Full Text] [Related]
24. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally.
Jaganathan KS; Vyas SP
Vaccine; 2006 May; 24(19):4201-11. PubMed ID: 16446012
[TBL] [Abstract][Full Text] [Related]
25. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices.
Jain RA
Biomaterials; 2000 Dec; 21(23):2475-90. PubMed ID: 11055295
[TBL] [Abstract][Full Text] [Related]
26. Biodegradable polymeric microparticles for drug delivery and vaccine formulation: the surface attachment of hydrophilic species using the concept of poly(ethylene glycol) anchoring segments.
Coombes AG; Tasker S; Lindblad M; Holmgren J; Hoste K; Toncheva V; Schacht E; Davies MC; Illum L; Davis SS
Biomaterials; 1997 Sep; 18(17):1153-61. PubMed ID: 9259512
[TBL] [Abstract][Full Text] [Related]
27. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
Delgado A; Lavelle EC; Hartshorne M; Davis SS
Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
[TBL] [Abstract][Full Text] [Related]
28. Poly D,L-lactide-co-glycolic acid (PLGA)-encapsulated vaccine on immune system in Epinephelus bruneus against Uronema marinum.
Harikrishnan R; Balasundaram C; Heo MS
Exp Parasitol; 2012 Jul; 131(3):325-32. PubMed ID: 22580022
[TBL] [Abstract][Full Text] [Related]
29. Biodegradable microparticles as oral vaccines.
O'Hagan DT; Jeffery H; Maloy KJ; Mowat AM; Rahman D; Challacombe SJ
Adv Exp Med Biol; 1995; 371B():1463-7. PubMed ID: 7502838
[No Abstract] [Full Text] [Related]
30. Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.
Pavot V; Berthet M; Rességuier J; Legaz S; Handké N; Gilbert SC; Paul S; Verrier B
Nanomedicine (Lond); 2014 Dec; 9(17):2703-18. PubMed ID: 25529572
[TBL] [Abstract][Full Text] [Related]
31. Studies on the potential of microparticles entrapping pDNA-poly(aminoacids) complexes as vaccine delivery systems.
Benoit MA; Ribet C; Distexhe J; Hermand D; Letesson JJ; Vandenhaute J; Gillard J
J Drug Target; 2001; 9(4):253-66. PubMed ID: 11697029
[TBL] [Abstract][Full Text] [Related]
32. Controlled release microparticles for vaccine development.
O'Hagan DT; Jeffery H; Roberts MJ; McGee JP; Davis SS
Vaccine; 1991 Oct; 9(10):768-71. PubMed ID: 1759495
[TBL] [Abstract][Full Text] [Related]
33. Poly-D,L-lactide-co-poly(ethylene glycol) microspheres as potential vaccine delivery systems.
Zhou S; Liao X; Li X; Deng X; Li H
J Control Release; 2003 Jan; 86(2-3):195-205. PubMed ID: 12526816
[TBL] [Abstract][Full Text] [Related]
34. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres.
Allaoui-Attarki K; Fattal E; Pecquet S; Trollé S; Chachaty E; Couvreur P; Andremont A
Vaccine; 1998 Apr; 16(7):685-91. PubMed ID: 9562687
[TBL] [Abstract][Full Text] [Related]
35. Poly-DL-lactide-co-glycolide microspheres as a controlled release antigen delivery system.
Lima KM; Rodrigues Júnior JM
Braz J Med Biol Res; 1999 Feb; 32(2):171-80. PubMed ID: 10347752
[TBL] [Abstract][Full Text] [Related]
36. Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches.
Jain R; Shah NH; Malick AW; Rhodes CT
Drug Dev Ind Pharm; 1998 Aug; 24(8):703-27. PubMed ID: 9876519
[TBL] [Abstract][Full Text] [Related]
37. Biodegradable poly(DL-lactide-co-glycolide) microspheres.
Eldridge JH; Staas JK; Tice TR; Gilley RM
Res Immunol; 1992 Jun; 143(5):557-63; discussion 581. PubMed ID: 1439138
[No Abstract] [Full Text] [Related]
38. Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination.
Johansen P; Men Y; Merkle HP; Gander B
Eur J Pharm Biopharm; 2000 Jul; 50(1):129-46. PubMed ID: 10840197
[TBL] [Abstract][Full Text] [Related]
39. The use of soluble polymers and polymer microparticles to provide improved vaccine responses after parenteral and mucosal delivery.
Davis SS
Vaccine; 2006 Apr; 24 Suppl 2():S2-7-10. PubMed ID: 16823907
[TBL] [Abstract][Full Text] [Related]
40. Charged polylactide co-glycolide microparticles as antigen delivery systems.
Singh M; Kazzaz J; Ugozzoli M; Chesko J; O'Hagan DT
Expert Opin Biol Ther; 2004 Apr; 4(4):483-91. PubMed ID: 15102598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
